| Literature DB >> 21092196 |
Andrew A Adjei1, Yao Tettey, John T Aviyase, Clement Adu-Gyamfi, Julius A Mingle, Edmund T Nartey.
Abstract
BACKGROUND: Several studies have suggested that elevated serum alanine aminotransferase (ALT) and asparte aminotransferase (AST) may be markers of hepatitis E virus (HEV) infection. Thus, individuals with elevated ALT and AST may have ongoing subclinical infection of HEV. We estimated the prevalence of anti-HEV antibodies and serum ALT and AST levels among persons who work with pigs in Accra, Ghana.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21092196 PMCID: PMC2995795 DOI: 10.1186/1743-422X-7-336
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
Age-specific Prevalence of Anti-HEV IgG and Anti-HEV IgM Among Pig Handlers.
| IgG | IgM | ||||||
|---|---|---|---|---|---|---|---|
| Age (yrs) | N | Positive | Negative | p-value | Positive | Negative | p-value |
| n (%) | n (%) | n (%) | n (%) | ||||
| ≤20 | 41 | 6 (14.63) | 35 (85.37) | 0.001 | 7 (17.07) | 34 (82.93) | < 0.001 |
| 21-25 | 55 | 12 (21.82) | 43 (78.18) | < 0.001 | 7 (12.73) | 48 (87.27) | < 0.001 |
| 26-30 | 82 | 16 (19.51) | 66 (80.49) | < 0.001 | 15 (18.29) | 67 (81.71) | < 0.001 |
| 31-35 | 56 | 12 (21.43) | 44 (78.57) | < 0.001 | 5 (8.93) | 51 (91.07) | < 0.001 |
| 36-40 | 38 | 4 (10.53) | 34 (89.47) | < 0.001 | 9 (23.68) | 29 (76.32) | 0.002 |
| 41-45 | 37 | 8 (21.62) | 29 (78.38) | 0.001 | 6 (16.22) | 31 (83.78) | < 0.001 |
| 46-50 | 13 | 3 (23.08) | 10 (76.92) | 0.092 | 1 (7.69) | 12 (92.31) | 0.003 |
| 51-55 | 14 | 5 (35.71) | 9 (64.29) | 0.429 | 0 (0) | 14 (100) | < 0.001* |
| 56-60 | 6 | 0 (0) | 6 (100) | 0.031* | 2 (33.33) | 4 (66.67) | 0.688 |
| > 60 | 11 | 2 (18.18) | 9 (81.82) | 0.065 | 3 (27.27) | 8 (72.73) | 0.277 |
*Binomial test used instead of Chi-square test; N values indicate number of responses obtained in each category
Comparison of Age-specific Distribution of HEV Sero-reactivity (IgG) and ALT Levels Among Pig Handlers.
| Number of ALT values | ||||||
|---|---|---|---|---|---|---|
| Age (yrs) | IgG status | > 69 U/L | ≤69 U/L | OR | 95% CI | P-value |
| ≤20 (n = 41) | 2 | 4 | Not estimable | Not estimable | 0.018 | |
| 0 | 35 | 1.00 | Baseline | |||
| 21-25 (n = 55) | 4 | 8 | 21.00 | 2.07-213.28 | 0.006 | |
| 1 | 42 | 1.00 | ||||
| 26-30 (n = 82) | 8 | 8 | 65.00 | 7.17-589.42 | 0.001 | |
| 1 | 65 | 1.00 | Baseline | |||
| 31-35 (n = 56) | 3 | 9 | 7.00 | 1.02-48.16 | 0.060 | |
| 2 | 42 | 1.00 | Baseline | |||
| 36-40 (n = 38) | 1 | 3 | 5.33 | 0.37-77.50 | 0.291 | |
| 2 | 32 | 1.00 | Baseline | |||
| 41-45 (n = 37) | 3 | 5 | 8.10 | 1.07-61.54 | 0.057 | |
| 2 | 27 | 1.00 | Baseline | |||
| 46-50 (n = 13) | 1 | 2 | 2.00 | 0.12-34.82 | 1.000 | |
| 2 | 8 | 1.00 | Baseline | |||
| 51-55 (n = 14) | 1 | 4 | Not estimable | Not estimable | 0.357 | |
| 0 | 9 | 1.00 | Baseline | |||
| 56-60 (n = 6) | 0 | 0 | Not estimable | Not estimable | Not estimable | |
| 0 | 6 | 1.00 | Baseline | |||
| > 60 (n = 11) | 0 | 2 | Not estimable | Not estimable | Not estimable | |
| 0 | 9 | 1.00 | Baseline | |||
OR, odds ratio; CI, confidence interval; n values indicate number of responses obtained in each category
Comparison of Age-specific Distribution of HEV Sero-reactivity (IgM) and ALT levels among pig handlers.
| Number of ALT values | ||||||
|---|---|---|---|---|---|---|
| Age (yrs) | IgM status | > 69 U/L | ≤69 U/L | OR | 95% CI | p-value |
| ≤ 20 (n = 41) | 4 | 3 | 44.00 | 3.65-530.55 | 0.002 | |
| 1 | 33 | 1.00 | Baseline | |||
| 21-25 (n = 55) | 5 | 2 | 37.50 | 5.01-280.90 | < 0.001 | |
| 3 | 45 | 1.00 | Baseline | |||
| 26-30 (n = 82) | 9 | 6 | 99.00 | 10.66-919.41 | < 0.001 | |
| 1 | 66 | 1.00 | Baseline | |||
| 31-35 (n = 56) | 3 | 2 | 36.75 | 3.76-359.45 | 0.003 | |
| 2 | 49 | 1.00 | Baseline | |||
| 36-40 (n = 38) | 5 | 4 | Not estimable | Not estimable | < 0.001 | |
| 0 | 29 | 1.00 | Baseline | |||
| 41-45 (n = 37) | 3 | 3 | Not estimable | Not estimable | 0.003 | |
| 0 | 31 | 1.00 | Baseline | |||
| 46-50 (n = 13) | 1 | 0 | Not estimable | Not estimable | 0.077 | |
| 0 | 12 | 1.00 | Baseline | |||
| 51-55 (n = 14) | 0 | 0 | Not estimable | Not estimable | Not estimable | |
| 0 | 14 | 1.00 | Baseline | |||
| 56-60 (n = 6) | 2 | 0 | Not estimable | Not estimable | 0.467 | |
| 2 | 2 | 1.00 | Baseline | |||
| > 60 (n = 11) | 3 | 0 | Not estimable | Not estimable | 0.182 | |
| 3 | 5 | 1.00 | Baseline | |||
OR, odds ratio; CI, confidence interval; n values indicate number of responses obtained in each category
Comparison of Age-specific Distribution of HEV Sero-reactivity (IgG) and AST Levels Among Pig Handlers.
| Number of AST values | ||||||
|---|---|---|---|---|---|---|
| Age (yrs) | IgG status | > 46 U/L | ≤46 U/L | OR | 95% CI | p-value |
| ≤20 (n = 41) | 1 | 5 | Not estimable | Not estimable | 0.146 | |
| 0 | 35 | 1.00 | Baseline | |||
| 21-25 (n = 55) | 3 | 9 | Not estimable | Not estimable | 0.008 | |
| 0 | 43 | 1.00 | Baseline | |||
| 26-30 (n = 82) | 6 | 10 | 19.20 | 3.39-108.68 | 0.001 | |
| 2 | 64 | 1.00 | Baseline | |||
| 31-35 (n = 56) | 3 | 9 | Not estimable | Not estimable | 0.008 | |
| 0 | 44 | 1.00 | Baseline | |||
| 36-40 (n = 38) | 0 | 4 | Not estimable | Not estimable | 1.000 | |
| 2 | 32 | 1.00 | Baseline | |||
| 41-45 (n = 37) | 3 | 5 | 3.75 | 0.63-22.20 | 0.308 | |
| 4 | 25 | 1.00 | Baseline | |||
| 46-50 (n = 13) | 1 | 2 | 2.00 | 0.12-34.82 | 1.000 | |
| 2 | 8 | 1.00 | Baseline | |||
| 51-55 (n = 14) | 0 | 5 | Not estimable | Not estimable | Not estimable | |
| 0 | 9 | 1.00 | Baseline | |||
| 56-60 (n = 6) | 0 | 0 | Not estimable | Not estimable | Not estimable | |
| 0 | 6 | 1.00 | Baseline | |||
| > 60 (n = 11) | 0 | 2 | Not estimable | Not estimable | 0.564 | |
| 3 | 6 | 1.00 | Baseline | |||
OR, odds ratio; CI, confidence interval; n values indicate number of responses obtained in each category
Comparison of Age-specific Distribution of HEV Sero-reactivity (IgM) and AST Levels Among Pig Handlers.
| Number of AST values | ||||||
|---|---|---|---|---|---|---|
| Age (yrs) | IgM status | > 46 U/L | ≤46 U/L | OR | 95% CI | p-value |
| ≤20 (n = 41) | 2 | 5 | Not estimable | Not estimable | 0.026 | |
| 0 | 34 | 1.00 | Baseline | |||
| 21-25 (n = 55) | 3 | 4 | 4.39 | 0.80-24.00 | 0.104 | |
| 7 | 41 | 1.00 | Baseline | |||
| 26-30 (n = 82) | 4 | 11 | 3.12 | 0.78-12.47 | 0.202 | |
| 7 | 60 | 1.00 | Baseline | |||
| 31-35 (n = 56) | 0 | 5 | Not estimable | Not estimable | 1.000 | |
| 2 | 49 | 1.00 | Baseline | |||
| 36-40 (n = 38) | 0 | 9 | Not estimable | Not estimable | Not estimable | |
| 0 | 29 | 1.00 | Baseline | |||
| 41-45 (n = 37) | 0 | 6 | Not estimable | Not estimable | Not estimable | |
| 0 | 31 | 1.00 | Baseline | |||
| 46-50 (n = 13) | 1 | 0 | Not estimable | Not estimable | 0.231 | |
| 2 | 10 | 1.00 | Baseline | |||
| 51-55 (n = 14) | 0 | 0 | Not estimable | Not estimable | Not estimable | |
| 3 | 11 | 1.00 | Baseline | |||
| 56-60 (n = 6) | 2 | 0 | Not estimable | Not estimable | Not estimable | |
| 4 | 0 | 1.00 | Baseline | |||
| > 60 (n = 11) | 2 | 1 | Not estimable | Not estimable | 0.055 | |
| 0 | 8 | 1.00 | Baseline | |||
OR, odds ratio; CI, confidence interval; n values indicate number of responses obtained in each category
Odds ratio for HEV sero-reactivity and corresponding 95% CI according to risk factors
| Characteristic | HEV positive | HEV negative | OR | 95% CI | p-value |
|---|---|---|---|---|---|
| Yes | 118 | 147 | 13.33 | 5.23-33.93 | < 0.001 |
| No | 5 | 83 | 1.00 | Baseline | |
| Yes | 101 | 111 | 4.92 | 2.90-8.35 | < 0.001 |
| No | 22 | 119 | 1.00 | Baseline | |
| Yes | 98 | 129 | 3.07 | 1.84-5.11 | < 0.001 |
| No | 25 | 101 | 1.00 | Baseline | |
| Yes | 89 | 109 | 2.91 | 1.81-4.66 | < 0.001 |
| No | 34 | 121 | 1.00 | Baseline | |
| Yes | 22 | 19 | 2.42 | 1.25-4.67 | 0.009 |
| No | 101 | 211 | 1.00 | Baseline | |
| Yes | 95 | 184 | 0.85 | 0.50-1.44 | 0.584 |
| No | 28 | 46 | 1.00 | Baseline | |
| Tertiary | 0 | 3 | Not estimable | Not estimable | 0.554 |
| Senior high | 2 | 8 | 0.56 | 0.11-2.70 | 0.518 |
| Basic | 62 | 88 | 1.56 | 1.00-2.45 | 0.053 |
| None | 59 | 131 | 1.00 | Baseline | |
| ≤6 months | 89 | 52 | 8.96 | 5.43-14.80 | < 0.001 |
| > 6 months | 34 | 178 | 1.00 | Baseline | |
OR, odds ratio; CI, confidence interval; n values indicate number of responses obtained in each category